Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy
COPENHAGEN, Denmark, Feb. 13, 2024 /PRNewswire/ -- Curasight A/S Curasight or the Company – has today resolved on a new issue of shares with preferential rights for the Company's existing...
Source: marketscreener.com